Stocks making the biggest moves midday: Chewy, Biogen, Snowflake and more [CNBC]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: CNBC
Snowflake – Shares of the cloud computing company dropped nearly 4%. The firm presented its financial targets at its investor day meeting on Thursday, aiming to reach $10 billion in annual product revenue by 2029, compared to $554 million in its fiscal year that ended in January. Vertex Pharmaceuticals — The pharmaceutical company’s shares fell over 10% in midday trading after it said on Thursday that it will stop developing an experimental drug after it was shown to be unlikely to prove effective against a rare genetic disease called AAT Deficiency. Vertex said its drug raised levels of a deficient protein, but not enough to grant a material health improvement. Chewy — Shares of the e-commerce pet company fell more than 5% despite earning an adjusted 9 cents per share for its latest quarter, compared to consensus forecasts for a 3 cents per share loss. Chewy, which reported earnings late Thursday, also saw revenue beat estimates and gave an upbeat revenue outlook. However, the comp
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies [Yahoo! Finance]Yahoo! Finance
- Vertex in-licenses cell therapy technology for diabetes candidates [Seeking Alpha]Seeking Alpha
- Global Vaccine Contract Manufacturing Market Trends Analysis Report 2024-2030: Capacity Expansion by Contract Manufacturers, & Vaccination Innovation and Robust Vaccine Pipeline Bolsters Growth [Yahoo! Finance]Yahoo! Finance
- Arcturus Therapeutics' ARCT-032: Might Be The Next Breakthrough In Cystic Fibrosis [Seeking Alpha]Seeking Alpha
- U.S. Gene Therapy Market Size, Share & Trends Analysis Report 2024-2030: Robust Pipeline and Growing Prevalence of Target Diseases Fueling Growth and Developments [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/5/24 - Beat
VRTX
Sec Filings
- 4/17/24 - Form 4
- 4/16/24 - Form PX14A6G
- 4/11/24 - Form SC
- VRTX's page on the SEC website